
Piper Sandler has decided to maintain its Overweight rating of Altimmune (NASDAQ:ALT) and lower its price target from $34.00 to $25.00.
Shares of Altimmune are trading down 0.57% over the last 24 hours, at $5.26 per share.

Piper Sandler has decided to maintain its Overweight rating of Altimmune (NASDAQ:ALT) and lower its price target from $34.00 to $25.00.
Shares of Altimmune are trading down 0.57% over the last 24 hours, at $5.26 per share.